The KPM Group DC LLC

The KPM Group DC LLC filed a registration for Inozyme Pharma on July 15, 2025.

Lobbying for Inozyme Pharma · Treatments for PPi-Adenosine Pathway, ENPP1 Deficiency, ABCC6 Deficiency, & calciphylaxis.

As filed: THE KPM GROUP DC LLC for INOZYME PHARMA.

All filings by The KPM Group DC LLC · Everything Inozyme Pharma has reported

Filing · LD-1 registration Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 15, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbying activity 1

Pharmacy

FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act

Bills named in this filing 5

H.R. 1262
Mikaela Naylon Give Kids a Chance Act
H.R. 946
ORPHAN Cures Act
H.R. 1414
Cameron’s Law
H.R. 1532
Scientific EXPERT Act of 2025
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.